05:37:16 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 26,121,425
Close 2022-08-12 C$ 0.23
Market Cap C$ 6,007,928
Recent Sedar Documents

Ndatalyze to drop extractors, to focus on YMI app

2022-08-16 17:19 ET - News Release

Mr. Jim Durward reports

NDATALYZE FOCUSES ON YMI FOR FUTURE GROWTH

Ndatalyze Corp. will focus on commercializing its YMI mental health application going forward and will be asking shareholders to approve the discontinuation of its extractor sales operation at the corporation's upcoming annual general and special shareholders meeting (AGSSM) that is expected to be held in November, 2022, with details to follow once the date is set. The background and mechanism of the discontinuation, which may involve a sale, spinout or other approach, will be disclosed in AGSSM documents when mailed to the shareholders. AGSSM documents will also be posted to the company's website, investors page, after mailing. The corporation also expects to file an updated listing statement with the Canadian Securities Exchange with respect to the aforementioned.

President Jim Durward states: "As we move forward with the corporation's development, we believe that our advanced YMI mental health product represents the corporation's best growth opportunity, and we want to provide a clear message to the market as to the corporation's future direction."

About Ndatalyze Corp.

Ndatalyze generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, on-line consumer mental health application with its database licensing division focusing on providing a specialized health-related reference database to application developers and researchers. YMI is based on the corporation's proprietary reference database consisting of greater than 1,200 biometric records complete with associated electroencephalogram (EEG) data. With installations worldwide, its Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development, and, accordingly, the corporation cannot accurately predict if or when this application will become a cash flow generator.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.